Coronavirus (COVID-19) Update: FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine as Booster Dose for Certain Children 6 Months through 4 Years of Age

For Immediate Release: March 14, 2023 Español Currently, the U.S. Food stuff and Drug Administration amended the crisis use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to provide for…

Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19

For Rapid Launch: December 16, 2022 Assertion From: Peter Marks, M.D., PhD. Director – Center for Biologics Analysis and Investigate (CBER) On Jan. 26, 2023, the U.S. Food stuff and…

SAMHSA Proposes Update to Federal Rules to Expand Access to Opioid Use Disorder Treatment and Help Close Gap in Care

Modifications Would Make Long-lasting COVID-Timed Treatment Flexibilities, and Update A long time-Old Definitions and Specifications for Opioid Treatment Programs at a time when fewer than 1 out 10 Us residents…

Coronavirus (COVID-19) Update: FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age

For Immediate Release: December 08, 2022 Español Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 vaccines to…

COVID-19 Update | Changes in CDC Recommendations

Pricey Users of the Campus Neighborhood, I am crafting to give you an update on University COVID-19 protocols. I hope your fall semester is heading well. I’m positive you are…

Coronavirus (COVID-19) Update: FDA Updates COVID-19 Test Policy, Encourages Developers to Seek Traditional Premarket Review for Most Test Types

For Instant Launch: September 27, 2022 Nowadays, the U.S. Foodstuff and Drug Administration updated its COVID-19 test coverage to make sure continued obtain to tests while encouraging the transition of…